Sinopharm Tech Holdings Limited

Equities

8156

KYG2159V1418

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
0.102 ^HKD	+2.00%		+2.00%	-22.73%

Feb. 29	Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Sinopharm Tech Holdings Limited Announces Management Changes	CI

Sinopharm Tech Holdings Limited Announces the Address Change of Head Office and Principal Place of Business in Hong Kong

September 01, 2022 at 10:08 am EDT

The board of directors of Sinopharm Tech Holdings Limited announced that the company's head office and principal place of business in Hong Kong will be changed to Units 15-16, 25/F., Corporation Park, 11 On Lai Street, Shatin, New Territories, Hong Kong with effect from 1 September 2022. The telephone number and facsimile number of the Company remain unchanged.

Latest news about Sinopharm Tech Holdings Limited

Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 29	CI
Sinopharm Tech Holdings Limited Announces Management Changes	Dec. 29	CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-29	CI
Sinopharm Tech Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2023	23-09-22	CI
Sinopharm Tech Holdings Limited Announces Change of Head Office and Principal Place of Business in Hong Kong	23-09-22	CI
Sinopharm Tech Holdings Limited Appoints HEUNG Pik Lun as an Independent Non-Executive Director and A Member of the Audit Committee and the Nomination Committee	23-09-15	CI
Sinopharm Tech Holdings Limited Announces Appointment of Mr. Hsu Dong an as an Independent Non-Executive Director, Chairperson of the Nomination Committee and Member of the Audit Committee, the Remuneration Committee and the Nomination Committee	23-08-15	CI
Sinopharm Tech Holdings Limited Announces Liu Ta-Pei Resigns as an Independent Non-Executive Director, Member of the Audit Committee the Remuneration Committee and the Nomination Committee	23-08-03	CI
Sinopharm Tech Holdings Limited Announces the Resignation of LAM Kit Sun as Independent Non-Executive Director, Member of the Audit Committee and the Remuneration Committee and the Chairperson and Member of the Nomination Committee	23-05-16	CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Sinopharm Tech Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended 31 March 2023	23-05-08	CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-14	CI
Sinopharm Tech Holdings Provides Earnings Guidance for the Six Months Ended December 31, 2022	23-02-06	CI
Sinopharm Tech Holdings Limited and Guangdong Tongguanyi Network Technology Co., Ltd. enters into A Joint Venture Agreement to Establish A Joint Venture	22-12-19	CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-14	CI
Sinopharm Tech Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Three Months Ended 30 September 2022	22-11-03	CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-30	CI
Sinopharm Tech Holdings Limited Auditor Raises 'Going Concern' Doubt	22-09-29	CI
Sinopharm Tech Holdings Limited Announces Management Changes	22-09-05	CI
Sinopharm Tech Holdings Limited Announces the Address Change of Head Office and Principal Place of Business in Hong Kong	22-09-01	CI
Chan Ting Resigns as CEO of Sinopharm Tech Holdings Limited	22-08-01	CI
Sinopharm Tech Holdings Limited Announces Board Changes	22-08-01	CI
Sinopharm Tech Holdings Limited Enters Cooperation Agreement with Tencent Cloud Computing Company Limited	22-05-24	CI
Sinopharm Tech Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-13	CI

Chart Sinopharm Tech Holdings Limited

Duration

Period

More charts

Company Profile

Sinopharm Tech Holdings Limited is an investment holding company principally engaged in internet services. Along with subsidiaries, the Company operates its business through three segments. The Internet Plus Services segment is involved in the provision of supply chain services including operation of supply chain technology platform, provision of supply chain management, data analysis and trading of goods. The segment also provides internet plus solution services for lease, government affairs, public security and other industries. The Lottery Related Services segment is engaged in the provision of lottery transaction systems, lottery point of sale (POS) terminals and other lottery solutions. The Other Services segment is engaged in the provision of services including catering services and consultancy services.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-12 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SINOPHARM TECH HOLDINGS LIMITED	-22.73%	2.35M
ABBOTT LABORATORIES	-2.65%	187B
MEDTRONIC PLC	-1.55%	106B
BECTON, DICKINSON AND COMPANY	-4.34%	66.9B
DEXCOM, INC.	+0.62%	49.45B
CENCORA, INC.	+16.63%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.61%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+1.18%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution